Wheat germ

Wheat Germ: A Comprehensive Encyclopedic Reference

1. Identity, Nomenclature, and Natural Source

Botanical and Chemical Identity

Wheat germ is the embryonic portion of the grain of Triticum aestivum L. (common bread wheat), the domesticated hexaploid cereal of the grass family Poaceae. The wheat germ is composed of two major anatomical parts: the embryonic axis (rudimentary root and shoot) and the scutellum, which functions as a storage organ. The scutellum is adjacent to the endosperm and contains a significant portion of the grain's thiamin content. The wheat germ (embryonic axis and scutellum combined) represents approximately 2.5–3.8% of total seed weight and is an important by-product of the flour milling industry.

Wheat germ is defined as the part of the wheat kernel that is rich in health-beneficial bioactive compounds, including phytosterols, tocopherols, carotenoids, and omega-3 fatty acids, and is used for its nutritional value, particularly in health foods and dietary supplements.

Common Forms and Preparations

Wheat germ is commercially available in several distinct preparations. The most fundamental distinction is between raw wheat germ (the intact, milled germ fraction), toasted/stabilized wheat germ (heat-treated to reduce rancidity), wheat germ oil (extracted by mechanical pressing or solvent), and fermented wheat germ extract (FWGE), a standardized nutraceutical product sold under brand names such as Avemar and MSC (Medical Nutritional Supplement for Cancer patients).

Oil recovery from wheat germ is achieved by mechanical pressing or solvent extraction, which retrieve approximately 50% or 90% of total lipids, respectively; innovative approaches such as supercritical carbon dioxide extraction are also proposed.

The standardized fermented wheat germ product (Avemar pulvis) is a powder consisting of an aqueous extract of fermented wheat germ combined with maltodextrin and silicon dioxide, standardized to contain approximately 200 μg/g of the natural constituent 2,6-dimethoxy-p-benzoquinone. Wheat germ is produced as a by-product during wheat milling operations and is a relatively inexpensive protein source that, in spite of its exclusive nutritional properties, is mostly used for animal feed formulation and has limited use in the food industry.

2. Traditional and Historical Use

Agricultural Origins

The association of humans with wheat cultivation and consumption began approximately 10,000 years BC. The history of wheat begins in the Fertile Crescent, an area stretching across parts of modern-day Iraq, Syria, Turkey, and Iran — a region often referred to as the "Cradle of Civilization" due to its role in the early development of agriculture. Wild wheat species, such as Triticum dicoccum (emmer wheat) and Triticum turgidum (einkorn wheat), were first cultivated here around 10,000 years ago. Wheat was cultivated in India around 3500 BC and likely appeared in China's lower Yellow River around 2600 BC.

In ancient pre-industrial milling, the entire grain — including the germ — was consumed in coarse wholemeal preparations. It was only with the advent of industrial roller milling in the 19th century that the germ was systematically separated from the endosperm. Wheat germ, corresponding to 2–3% of the total weight of the wheat kernel, is almost systematically removed during milling since it adversely affects the shelf-life and the processing quality of flour.

Scientific Rediscovery and the Vitamin E Connection

The modern scientific history of wheat germ as a distinct nutritional entity began in the early 20th century. Wheat germ is one of the richest sources of α-tocopherol (α-TOH) in the plant kingdom and was one of the first food ingredients used in the pioneering studies that led to the identification of vitamin E as an essential nutrient important in animal fertility. In 1922, Herbert McLean Evans and Katharine Scott Bishop, conducting feeding experiments on rats at Berkeley, identified a fat-soluble dietary factor whose absence caused reproductive failure. Lettuce was the first food found to prevent this problem, but then wheat and in particular wheat germ oil proved effective. The active factor was named "vitamin E" and, following further investigations by many groups, it was isolated in 1935 and named "tocopherol." Evans and his co-worker George Burr prepared a potent concentrate of vitamin E by saponification of wheat germ oil, which proved to possess high biological potency; wheat germ oil-based concentrates were used in many further experiments on vitamin E and served as a source for the development of the first commercial vitamin E products in the 1930s.

In 1936, Evans and his co-workers isolated two compounds with vitamin E activity from wheat germ oil, for which they proposed the names α-tocopherol and β-tocopherol. With Gladys Anderson Emerson, Evans reported the isolation of pure vitamin E from wheat germ in 1937, and also determined its formula C₂₉H₅₀O₂.

Wheat germ was the experimental material in which the stability of vitamin E was first associated with processes of lipid autoxidation and with its "antioxygenic" properties. This body of work established wheat germ as a canonical reference material in nutritional science and prompted its subsequent commercial development as a dietary supplement.

3. Key Constituents and Active Compounds

Macronutrient Composition

The germ contains approximately 10–15% lipids, 26–35% proteins, 17% sugars, 1.5–4.5% fibre, and 4% minerals, as well as significant quantities of bioactive compounds such as tocopherols (300–740 mg/kg dry matter), phytosterols (24–50 mg/kg), policosanols (10 mg/kg), carotenoids (4–38 mg/kg), thiamin (15–23 mg/kg), and riboflavin (6–10 mg/kg).

The main by-product of oil extraction is defatted germ meal, which has a high protein content of 30–32%, is rich in albumin (34.5% of total protein) and globulin (15.6%), and thus presents a well-balanced amino acid profile. Its principal mineral constituents are potassium, magnesium, calcium, zinc, and manganese, in decreasing order. Total flavonoid content is approximately 0.35 g rutin equivalent/100 g dry matter.

Vitamin E (Tocopherols and Tocotrienols)

Wheat germ is a rich source of phytosterols, policosanols, unsaturated fatty acids, protein, lipase, acid phosphatase, flavonoids, B vitamins, dietary fiber, and minerals. It is the richest known source of plant-derived vitamin E; tocopherols are powerful fat-soluble antioxidants. Relative concentrations of α-tocopherol in wheat germ oil are the highest among edible oils, ranging from 100 to 300 mg/100 g of oil. α-Tocopherol accounts for up to 60% of the tocopherol profile in wheat germ oil, contributing significantly to its antioxidant capacity. A characterized preparation of wheat germ oil (Triticum aestivum L. germ oil) has been described with a relative composition of approximately: min. 60% α-tocopherol, 25–30% γ+β-tocopherol, 5–8% γ-tocotrienol, and other forms at less than 1%.

Fatty Acid Profile

Linoleic acid at 56% is the predominant fatty acid in wheat germ oil, followed by palmitic acid (16%), oleic acid (13%), linolenic acid (8%), and stearic acid (0.8%). The oil is rich in triglycerides (57% of total lipids), mainly linoleic (18:2), palmitic (16:0), and oleic (18:1) acids, but relevant amounts of sterols, mono- and diglycerides, and phospho- and glycolipids are also present.

Additionally, wheat germ oil has been shown to contain high levels of linoleic acid (45.3%), squalene (2.52 g/100 g), and polyphenols.

Phytosterols and Policosanols

The presence of phytosterols in wheat germ oil, such as β-sitosterol and campesterol, adds cholesterol-lowering and anti-inflammatory properties to the oil's bioactive profile. Cold-pressed wheat germ oil has been found to have the highest content of octacosanol, β-sitosterol, and α-linolenic acid, which are suggested to be essential for potent anti-cyclooxygenase activity.

Spermidine (Polyamine)

Although spermidine (SPD) is well-reported to be contained in various plant-based foods, wheat germ is the richest source of SPD and is the source of various non-synthetic SPD supplements on the market today, and is also used in experiments on autophagy and inflammaging. One of the best-known grain dietary sources of spermidine is wheat germ, containing as much as 243 mg/kg.

Fermented Wheat Germ Extract (FWGE): Unique Active Compounds

Fermented wheat germ extract (FWGE) is a multisubstance composition that, among other constituents, contains 2-methoxy benzoquinone and 2,6-dimethoxy benzoquinone, which are likely to exert some of its biological effects. During fermentation, the release of the non-glycosylated and physiologically active 2-methoxy benzoquinone and 2,6-dimethoxybenzoquinone is almost completed during 24 hours; compared to control, the concentration of these bioactive compounds increases almost 4- and 6-fold.

Enzymes are considerably found in wheat germ, the most important of which include lipase and acid phosphatase. Wheat germ also contains the lectin wheat germ agglutinin (WGA). Wheat germ agglutinin (WGA) is a lectin that protects wheat (Triticum) from insects, yeast and bacteria; as an agglutinin protein, it binds to N-acetyl-D-glucosamine and sialic acid.

Additional Micronutrients

Antioxidants found in wheat germ include carotenoids, tocopherols, flavonoids, and phenolic acids. Due to the high concentration of functional compounds, wheat germ is one of the most attractive and promising sources of α-tocopherol, vitamins of group B, dietary fiber, polyunsaturated fats, minerals, and phytochemicals.

4. Mechanisms of Action

Antioxidant Activity

The predominant antioxidant mechanism of wheat germ is attributable to its tocopherol content. The health-promoting properties of wheat germ oil include increased antioxidant protection of tissues, which has primarily been associated with its vitamin E antioxidant function. Tocopherols protect cellular structures against oxidative damage and support overall cellular health. The lipid-rich matrix of the germ provides a medium in which fat-soluble antioxidants can function both within the food matrix and, following ingestion, within biological membranes.

Anti-inflammatory Mechanisms

Wheat germ oil contains cyclooxygenase and trypsin inhibitors, which are promising therapeutic targets for the treatment of various inflammatory diseases. Wheat germ oil showed anti-inflammatory activities via the fatty acid binding protein FABP4, interacting physically with target genes (77.84%) and by co-expressing with 8.01% of genes; primary targets for inflammatory pathways were PPARα, PPARγ, LPL, LEP, and ADIPOQ, as depicted by gene network enrichment analysis.

Mechanisms of Fermented Wheat Germ Extract

Biochemically, FWGE interferes with anaerobic glycolysis, the pentose cycle, and ribonucleotide reductase. Four mechanisms of action are postulated: a metabolic effect, an antiproliferative effect, an antimetastatic effect, and an immunological effect.

Activities of glucose-6-phosphate dehydrogenase and transketolase are inhibited by FWGE in a dose-dependent fashion, which correlates with decreased carbon incorporation and pentose cycle substrate flow into RNA ribose; this decrease in pentose cycle enzyme activities and carbon flow toward nucleic acid precursor synthesis provides the mechanistic understanding of the cell growth-controlling and apoptosis-inducing effects of fermented wheat germ.

FWGE has significant antiproliferative effects and kills tumor cells by the induction of apoptosis via the caspase–poly(ADP-ribose) polymerase pathway. In addition, FWGE modulates immune response by downregulation of the MHC-I complex and the induction of TNF-α and various interleukins.

Spermidine and Autophagy

Externally supplied spermidine prolongs lifespan, activates autophagy, improves mitochondrial function, and refills polyamine pools that decline during aging in various tissues of model organisms, including mice. Spermidine has been characterized as a natural autophagy inducer — autophagy being a process by which cells remove parts that are no longer needed or do not work correctly, helping cells stay healthy and promoting longevity.

5. Scientific Evidence by Area of Application

5.1 Cardiovascular and Lipid Metabolism

Several human studies have examined whether wheat germ supplementation can modify cardiovascular risk markers, but the collective evidence from controlled trials is mixed to null.

An early, small uncontrolled clinical study involving 10 hypercholesterolaemic adults (none obese or diabetic) examined the effect of 30 g per day of raw wheat germ supplementation over 4 weeks. Subjects ingested a daily supplement of 30 g of wheat germ over a 4-week period and returned to their usual basal diet for a 4-week follow-up; fasting blood samples were taken at the end of each period. After 4 weeks of wheat germ intake, glycemia did not change while total plasma cholesterol significantly decreased from 7.80 to 7.15 mM (paired Student's t-test, p ≤ 0.05). This study was small, uncontrolled, and cannot establish causation.

A subsequent double-blind, randomized, parallel placebo-controlled study investigated the effect of wheat germ policosanol (WGP) specifically on lipid profiles. 58 adults (30 men and 28 women, aged 49 ± 11 years) with normal to mildly elevated plasma cholesterol concentrations consumed chocolate pellets with or without 20 mg/day WGP for 4 weeks. Over the 4 weeks, neither the WGP nor the control treatment significantly changed plasma total cholesterol, LDL- and HDL-cholesterol, or triacylglycerol concentrations.

A more recent randomized, double-blinded, crossover, placebo-controlled clinical trial examined bread enriched with wheat germ in a healthy population. 55 healthy volunteers aged 18–60 consumed wheat germ-enriched bread containing 6 g of wheat germ compared with non-enriched bread over a 4-week period with a 15-week follow-up. No significant effect of daily wheat germ intake on cholesterol, triglycerides, postprandial glucose response, or insulin sensitivity was observed; incremental area under the curve for glucose and HOMA-IR did not change, suggesting that 6 g of wheat germ has no effect on glucose metabolism.

The results of available RCTs were synthesized in a 2020 systematic review and meta-analysis. This systematic review and meta-analysis aimed to evaluate the association of wheat germ interventions with metabolic markers; an electronic search was performed up to May 2019 in PubMed, Google Scholar, and Web of Science. 33 randomized controlled trials were identified, of which 10 were suitable; three biomarkers in five eligible studies were investigated by meta-analysis. Total cholesterol showed non-significant results (p = 0.98), with a standard mean difference (SMD) of −0.01 (95% CI: −0.17, 0.16). The SMD was −0.06 (95% CI: −0.41, 0.29, n = 4) for triglycerides and −0.09 (95% CI: −0.62, 0.45, n = 2) for glucose.

Evidence strength: Based on current published RCTs and a 2020 meta-analysis, the available clinical evidence does not support a significant effect of wheat germ supplementation (at doses used in trials) on total cholesterol, LDL, HDL, triglycerides, or fasting glucose in healthy individuals. Earlier positive findings in hypercholesterolaemic subjects were from very small uncontrolled studies. The overall evidence is weak and insufficient to draw definitive conclusions.

5.2 Cancer (Fermented Wheat Germ Extract — FWGE/Avemar)

The most substantial body of human clinical investigation surrounding wheat germ as a supplement concerns FWGE (Avemar), a standardized, industrially fermented form distinct from raw wheat germ. The FWGE nutraceutical (Avemar), manufactured under "good manufacturing practice" conditions and fulfilling the self-affirmed "generally recognized as safe" (GRAS) status in the United States, has been approved as a "dietary food for special medical purposes for cancer patients" in Europe.

Taken orally, Avemar can inhibit metastatic tumor dissemination and proliferation during and after chemotherapy, surgery, or radiation; benefits of Avemar treatment have been demonstrated in various human cancers, in cultures of in vitro grown cancer cells, in the prevention of chemical carcinogenesis, and also in some autoimmune conditions.

A key human clinical trial was a randomized, pilot, phase II study in melanoma patients. In this randomized pilot phase II clinical trial, the efficacy of dacarbazine (DTIC)-based adjuvant chemotherapy on survival parameters of melanoma patients was compared to that of the same treatment supplemented with a 1-year long administration of FWGE. At the end of an additional 7-year follow-up period, log-rank analyses (Kaplan-Meier estimates) showed significant differences in both progression-free (PFS) and overall survival (OS) in favor of the FWGE group.

Preclinical work has also demonstrated cytotoxic activity in a broad range of human cancer cell lines. Studies have demonstrated that wheat germ extract fermented with Saccharomyces cerevisiae possesses antioxidant, anti-inflammatory, and anticarcinogenic effects in a range of human cancer cell lines, including testicular, colon, melanoma, and leukemia cells. An inhibitory activity on ribonucleotide reductase has also been demonstrated for FWGE, allowing it to interfere with nucleic acid synthesis by several pathways; beside its single-agent cytotoxic activity against human tumor cell lines and human tumor xenografts, some data suggest synergistic drug interaction between 5-FU or DTIC in a limited number of cell lines.

These studies suggest there may be a role for Avemar in decreasing the progression of the disease, potentiating conventional treatments such as chemotherapy and radiotherapy, improving quality of life for sufferers, and potentially lessening side effects of conventional treatment.

Evidence strength: A 2025 systematic review assessed the overall body of FWGE human research. While findings suggest that FWGE may possess therapeutic potential, especially in oncology, the strength of evidence remains limited; of the six included human studies, only four employed proper control groups and only two demonstrated high methodological quality. The current evidence base is insufficient to draw definitive conclusions, and well-designed clinical trials are needed to strengthen this evidence. The mechanistic data from in vitro and animal studies is more robust than the current human trial evidence base.

5.3 Cognitive Function and Aging (Spermidine)

Wheat germ's spermidine content has attracted interest in cognitive aging research. Animal evidence is encouraging: in mice, oral spermidine supplementation increased lifespan by approximately 10% and mitigated age-related cardiovascular decline.

A Phase II randomized, placebo-controlled, double-blind human trial was conducted using a spermidine-rich wheat germ extract. In a human cohort of participants with subjective cognitive decline (n=30, 60 to 80 years of age), a 3-month randomized, placebo-controlled, double-blind Phase II trial was conducted with supplementation of the spermidine-rich plant extract (dosage: 1.2 mg/day). This was primarily a safety and tolerability study; cognitive outcomes were a secondary endpoint.

A larger subsequent randomized clinical trial of spermidine in older adults with cognitive decline found different results. A randomized trial of spermidine (extracted from wheat germ) failed to find improvements in memory in older adults with cognitive decline.

Evidence strength: Human evidence for spermidine-from-wheat-germ supplementation improving cognition remains limited and mixed. Animal and mechanistic data are more developed. The field is early-stage; the dose, duration, and population required for clinical benefit have not been established.

5.4 Primary Dysmenorrhea

A randomized, triple-blinded clinical trial investigated the effect of wheat germ extract on menstrual pain. This triple-blinded clinical trial was performed on 80 employed women affiliated with Hamadan University of Medical Sciences (Hamadan, Iran), allocated to two groups. Three 400-mg capsules of wheat germ extract or placebo were administered daily between the 16th day of the menstrual cycle to the fifth day of the next menstrual cycle for two consecutive months; pain intensity was measured by a visual analogue scale three times a day.

The rationale was based on the known contributions of individual wheat germ constituents: various studies have been conducted to assess the positive effects of some wheat germ compounds (vitamins E, B₆, and B₁) on reducing symptoms of dysmenorrhea. Proctor and Farquhar reported the efficiency of vitamin B₆ in relieving symptoms of dysmenorrhea; vitamin E intake reduces the intensity of dysmenorrhea; positive effects of vitamin B₁ in dysmenorrhea have also been addressed.

Evidence strength: This was a single, geographically restricted trial. Evidence is preliminary; larger, multi-centre replication is required.

5.5 Oxidative Stress and Hepatoprotection

In vitro and cell-based research has assessed the hepatoprotective potential of wheat germ oil's vitamin E fraction. Wheat germ oil is rich in α-tocopherol, a vitamin that has long been suggested to exert hepatoprotective effects; this function and its transcriptomics fingerprint were investigated in comparison with other tocopherol forms in human liver cells treated with oleic acid to develop steatosis and lipotoxicity. Used in chemoprevention mode, all vitamin E formulations afforded significant reduction of oleic-acid-induced steatosis and its consequent impact on lipotoxicity indicators, including ROS production and apoptotic and necrotic cell death. This was a cell-based (in vitro) study; human clinical translation remains undemonstrated.

Evidence strength: Preliminary — in vitro only. No human clinical trials on wheat germ oil for hepatoprotection have been identified in the peer-reviewed literature as of the searches conducted.

5.6 Anti-inflammatory Effects

Among tested wheat germ oil samples, cold-pressed oil exhibited the strongest inhibitory activity against proteinase (93.4%, IC₅₀ = 195.7 μg/mL) and cyclooxygenase 1 (80.5%, IC₅₀ = 58.6 μg/mL). These results are from in vitro enzyme assay models.

Phenolic compounds present in wheat germ oil further enhance its ability to reduce oxidative stress, thus mitigating cellular damage and supporting longevity.

Evidence strength: Anti-inflammatory effects are well-documented in vitro and through molecular pathway analysis. Human clinical evidence for whole wheat germ or wheat germ oil specifically as an anti-inflammatory agent is lacking as an established, validated clinical endpoint.

6. Body Systems and Associated Health Areas

• Cardiovascular system: Studied for effects on cholesterol, triglycerides, and endothelial function via policosanols, phytosterols, and unsaturated fatty acids. The acceptable percentage of unsaturated fatty acids in wheat germ oil plays an important role in lowering blood cholesterol and in the treatment of atherosclerosis and heart disease. Clinical evidence from RCTs is not supportive of significant effects at low-to-moderate supplemental doses in healthy populations.
• Immune and oncological system: FWGE has been studied as an adjunct in cancer patients. Highlighted properties of Avemar include: promotion of apoptosis of cancer cells whilst leaving normal cells unharmed, reduction of sugar supply required by cancer cells to survive, unmasking of cancer cells so they can be more readily targeted by the immune system, and prevention of abnormal cells from repairing themselves.
• Neurological and aging: Spermidine from wheat germ has been investigated in the context of autophagy, neuroprotection, and cognitive aging.
• Reproductive and menstrual: Studied for primary dysmenorrhea, supported by the known activity of individual constituents (vitamins E, B₆, B₁).
• Gastrointestinal: The effects of wheat (and wheat germ) on human physiology are grouped into nutritional, mechanical (mainly due to fiber content), and antioxidant (mainly due to phenolic acids and alkylresorcinols).
• Dermatological: Wheat germ oil is readily absorbed by human skin, making it an effective moisturizer and an appropriate topical treatment. Wheat germ oil is a rich source of vitamin E, which helps reduce skin damage, fight free radicals, support healthy collagen formation, and maintain even skin tone.

7. Dosage Forms and Reported Study Dosages

Multiple preparations are used in research and commerce. Dosages cited below reflect those reported in specific source studies and should not be interpreted as established therapeutic recommendations.

• Raw/toasted wheat germ (powdered or flake): A daily supplement of 30 g of wheat germ was used in a 4-week lipid-lowering study in hypercholesterolaemic subjects. Intervention studies used daily supplementation of 20 or 30 g/day during 4-week periods.
• Wheat germ-enriched bread: Wheat germ-enriched bread containing 6 g of wheat germ per serving was consumed over a 4-week period in a randomized trial in healthy adults.
• Wheat germ policosanol: 20 mg/day of wheat germ policosanol was administered for 4 weeks in a double-blind, randomized, parallel placebo-controlled study of 58 adults.
• Wheat germ extract capsules (dysmenorrhea study): Three 400-mg capsules of wheat germ extract were administered daily from the 16th day of the menstrual cycle to the 5th day of the next menstrual cycle for two consecutive months.
• Spermidine-enriched wheat germ extract: A dosage of 1.2 mg/day of spermidine via wheat germ extract was used in a 3-month Phase II randomized, placebo-controlled, double-blind trial in older adults with subjective cognitive decline.
• Fermented wheat germ extract (FWGE/Avemar): Avemar pulvis is standardized to contain approximately 200 μg/g of 2,6-dimethoxy-p-benzoquinone. In the melanoma Phase II trial, FWGE was administered for 1 year as an adjunct to dacarbazine-based chemotherapy in a randomized pilot phase II clinical trial.

8. Safety Considerations and Interactions

Wheat Allergy

Wheat germ contains proteins present across the whole wheat kernel and is not suitable for individuals with IgE-mediated wheat allergy. Wheat allergy results from an adverse immunologic (IgE-mediated) reaction to proteins in wheat and reactions can cause typical allergy symptoms involving the skin, gastrointestinal tract, respiratory system, and anaphylaxis in some individuals. The allergy or allergies are often caused by reactions to the storage proteins present in a wheat seed.

Celiac Disease and Gluten Sensitivity

Wheat germ is not appropriate for individuals with celiac disease. Celiac disease is an autoimmune disease of the gut involving IgA and IgG antibodies that form against gliadin, resulting in symptoms such as intestinal malabsorption, greasy, smelly diarrhea, abdominal pain, and bloating. Wheat allergy may be confused with celiac disease, especially since both involve a reaction to gluten; however, celiac disease is not the same as IgE-mediated wheat allergy. Current evidence indicates that allergy to ingested wheat and coeliac disease each occur in up to approximately 1% of the population.

Rancidity and Stability

A critical practical safety and quality concern with wheat germ is its marked susceptibility to oxidative rancidity, which reduces nutritional quality and may produce harmful lipid oxidation products. Wheat germ is quite susceptible to deterioration due to the presence of lipase (LA) and lipoxygenase (LOX); it is therefore indispensable to adopt a stabilization step to decrease the activity of LA and LOX while retaining a maximum level of nutrients. Thermal stabilization (e.g., infrared radiation, heat treatment) or refrigerated storage is required to maintain quality.

Wheat Germ Agglutinin (Lectin)

Wheat germ contains the lectin wheat germ agglutinin (WGA). Wheat germ agglutinin (WGA) is one of the most extensively studied plant lectins for its high stability, low toxicity, resistance to proteolytic degradation, and specific recognition and binding to glycosylated membrane components on the intestinal mucosal surface. The significance of dietary WGA for human health at typical consumption levels has not been definitively established in clinical studies.

FWGE Safety Profile

The safety of spermidine-enriched wheat germ extract was assessed in a preclinical tolerability study. Supplementation of spermidine using this extract did not result in morbidities or changes in behavior in BALBc/Rj mice during a 28-days repeated-dose tolerance study; post mortem examination of the mice organs showed no increase in tumorigenic and fibrotic events.

Potential Interactions with Anticancer Drugs

FWGE interacts synergistically with a variety of different anticancer drugs and has exerted antimetastatic properties in mouse models. The clinical implication of this synergy for patients on chemotherapy regimens requires careful consideration and has been examined in some of the Phase II clinical trials noted above; no documented adverse pharmacokinetic interaction with specific oncology drugs has been established in published human trials at the time of writing.

Population Considerations

The meta-analyses of prospective studies reported a low germ intake of 1 g/day average (ranging from 0.2 to 2.9 g/day), while the intervention studies used a daily supplementation of 20 or 30 g/day during the 4-week period. The discrepancy between habitual dietary intake and supplemental doses used in trials complicates direct interpretation of dose–effect relationships.

References

• PubMed: Chemical Composition and in vitro Anti-inflammatory Activity of Wheat Germ Oil Depending on the Extraction Procedure (2021)
• PubMed: Fermented wheat germ extract — nutritional supplement or anticancer drug? (2011)
• PubMed: Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells (2002)
• ScienceDirect Topics: Wheat Germ — an overview
• PubMed: An Insight into Wheat Germ Oil Nutrition, Identification of Its Bioactive Constituents and Computer-Aided Multidimensional Data Analysis (2023)
• PMC: Synthesis of 2-methoxy benzoquinone and 2,6-dimethoxybenzoquinone by selected lactic acid bacteria during sourdough fermentation of wheat germ (2013)
• PMC: Physicochemical properties and enzymatic activity of wheat germ extract microencapsulated with spray and freeze drying (2021)
• PubMed: Wheat germ: not only a by-product (2012)
• PMC: Does intake of bread supplemented with wheat germ have a preventive role on cardiovascular disease risk markers in healthy volunteers? A randomised, controlled, crossover trial (2019)
• PubMed: Does intake of bread supplemented with wheat germ have a preventive role on cardiovascular disease risk markers (2019)
• PMC: Effect of wheat germ on metabolic markers: a systematic review and meta-analysis of randomized controlled trials (2020)
• PubMed: Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations (2004)
• PubMed: Plasma lipid lowering effects of wheat germ in hypercholesterolaemic subjects (1991)
• Annals of the New York Academy of Sciences: Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases (2005)
• PubMed: The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review (2016)
• PubMed: Adjuvant fermented wheat germ extract (Avemar) nutraceutical improves survival of high-risk skin melanoma patients: a randomized, pilot, phase II clinical study with a 7-year follow-up (2008)
• PMC: Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines (2011)
• Frontiers in Nutrition: A systematic review on the health effects of fermented wheat germ extract with emphasis on cancer (2025)
• Memorial Sloan Kettering Cancer Center: Wheat Germ Extract
• PMC: Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline (2018)
• PMC: Effects of Wheat Germ Extract on the Severity and Systemic Symptoms of Primary Dysmenorrhea: A Randomized Controlled Clinical Trial (2014)
• PMC: Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity (2022)
• PMC: Molecular Profiling and FTIR Characterization of Wheat Germ Oil, Supported by the Screening of Its Anti-Inflammatory and Cytotoxic Properties (2025)
• PMC: Inactivation of Lipase and Lipoxygenase of Wheat Germ with Temperature-Controlled Short Wave Infrared Radiation (2016)
• MDPI Agriculture: A Century of Vitamin E: Early Milestones and Future Directions in Animal Nutrition (2023)
• Wikipedia: Herbert McLean Evans
• Journal of Nutrition: A Short History of Nutritional Science: Part 3 (1912–1944)
• Journal of Nutrition: The Discovery of the Antioxidant Function of Vitamin E: the contribution of Henry A. Mattill (2005)
• PubMed: The isolation from wheat germ oil of an alcohol, alpha-tocopherol, having the properties of vitamin E. By Herbert M. Evans, Oliver H. Emerson, and Gladys A. Emerson (1936)
• PMC: Spermidine-induced hypusination preserves mitochondrial and cognitive function during aging (2021)
• MDPI Applied Sciences: Wheat Germ Agglutinin — From Toxicity to Biomedical Applications (2021)
• Food Allergy Research & Education (FARE): Wheat Allergy
• PMC: Do we need to worry about eating wheat? (2016)
• PMC: Spermidine-Eugenol Supplement Preserved Inflammation-Challenged Intestinal Cells by Stimulating Autophagy (2023)